FAZ Wissen
Die Paper zu dieser Podcast-Folge:
- Europäische Zulassung Omikron-Impfstoffe "ECDC-EMA statement on booster vaccination with Omicron adapted bivalent COVID-19 vaccines"
- Ewen Callaway, Nature, 2022, "New Omicron-specific vaccines offer similar protection to existing boosters"
- Deborah Cromer et al, medRxiv, 2022, "Predicting the efficacy of variant-modified COVID-19 vaccine boosters"
- Susan Moir et al, medRxiv, 2022, "Recent SARS-CoV-2 infection abrogates antibody and B-cell responses to booster vaccination"
- Michael Edelstein et al, npj Vaccines, 2022, "Association between BNT162b2 vaccination and reported incidence of post-COVID-19 symptoms: cross-sectional study 2020-21, Israel"
- Liu Schan-Lu et al, New England Journal of Medicine, 2022, "Durability of Booster mRNA Vaccine against SARS-CoV-2 BA.2.12.1, BA.4, and BA.5 Subvariants"
Fler avsnitt av F.A.Z. Wissen
Visa alla avsnitt av F.A.Z. WissenF.A.Z. Wissen med Frankfurter Allgemeine Zeitung finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.
